
Trump’s MAGA Inc. Commits $10 Million to Texas Senate Race as Republicans Urge Greater Spending
By JOSEPH CURL
|The Biden administration could be backing away from its full embrace of the ‘Harm Reduction’ approach to drug use.

Is the Biden administration backing away from its tenuous support for supervised injection sites? The Department of Justice’s latest move regarding Philadelphia’s contentious Safehouse supervised injection site case indicates so — and reelection politics are likely at play.

By JOSEPH CURL
|
By JOSEPH CURL
|
By GEORGE WILLIS
|
By DAVID JONES
|
By JOSEPH CURL
|
By DEAN KARAYANIS
|
By HOLLIE McKAY
|
By ALEX ZDAN
|Is the Biden administration backing away from its tenuous support for supervised injection sites? The Department of Justice’s latest move regarding Philadelphia’s contentious Safehouse supervised injection site case indicates so — and reelection politics are likely at play.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.